Glimepiride

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8846 publications

Association of pioglitazone versus dipeptidyl peptidase-4 inhibitor use with incident gout in type 2 diabetes: a real-world cohort study.

Association of pioglitazone versus dipeptidyl peptidase-4 inhibitor use with incident gout in type 2 diabetes: a real-world cohort study.

Journal: Acta clinica Belgica

Published: August 10, 2026

Expert Consensus and Physician Perspectives on a Low-dose Triple Fixed-dose Combination for Type 2 Diabetes in India.

Expert Consensus and Physician Perspectives on a Low-dose Triple Fixed-dose Combination for Type 2 Diabetes in India.

Journal: The Journal of the Association of Physicians of India

Published: August 03, 2026

Molecular docking analysis of the interaction between metformin/glimepiride combination and organic cation transporter in diabetic patients.

Molecular docking analysis of the interaction between metformin/glimepiride combination and organic cation transporter in diabetic patients.

Journal: Wiadomosci lekarskie (Warsaw, Poland : 1960)

Published: July 31, 2026

Predicting pHmax and Salt Disproportionation Risk for Basic Drugs.

Predicting pHmax and Salt Disproportionation Risk for Basic Drugs.

Journal: Molecular pharmaceutics

Published: July 23, 2026

Pharmacologic Treatments for MASLD: A Review of Efficacy and Safety Considerations.

Pharmacologic Treatments for MASLD: A Review of Efficacy and Safety Considerations.

Journal: The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians

Published: July 22, 2026

Temporal trends and clinical factors associated with hypoglycemia-related hospitalization of patients with type 2 diabetes: a large-scale claims database study in Japan.

Temporal trends and clinical factors associated with hypoglycemia-related hospitalization of patients with type 2 diabetes: a large-scale claims database study in Japan.

Journal: Diabetes research and clinical practice

Published: July 17, 2026

Disease-modifying anti-diabetic drugs (DMADDs): bridging the SIMPLE approach to disease interception.

Disease-modifying anti-diabetic drugs (DMADDs): bridging the SIMPLE approach to disease interception.

Journal: Cardiovascular diabetology

Published: July 09, 2026

Albuminuria Not Attributable to Diabetic or Hypertensive Kidney Disease: Adult-Onset Minimal Change Disease Presenting With Nephrotic Syndrome in a Woman With Prediabetes and Hypertension.

Albuminuria Not Attributable to Diabetic or Hypertensive Kidney Disease: Adult-Onset Minimal Change Disease Presenting With Nephrotic Syndrome in a Woman With Prediabetes and Hypertension.

Journal: Cureus

Published: June 30, 2026

Efficacy and Safety of Pioglitazone Added to Metformin and SGLT2 Inhibitors in Type 2 Diabetes: An Updated Systematic Review and Meta-analysis.

Efficacy and Safety of Pioglitazone Added to Metformin and SGLT2 Inhibitors in Type 2 Diabetes: An Updated Systematic Review and Meta-analysis.

Journal: The Annals of pharmacotherapy

Published: June 28, 2026

Adipose Tissue Dysfunction in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Adipose Tissue Dysfunction in Metabolic Dysfunction-Associated Steatotic Liver Disease.

Journal: Cells

Published: June 25, 2026

Correction to "Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?"

Correction to "Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?"

Journal: PPAR research

Published: June 24, 2026

Pioglitazone in Skin Fibrosis: Mechanistic Rationale and Therapeutic Potential of Pioglitazone for Scarring Dermatoses.

Pioglitazone in Skin Fibrosis: Mechanistic Rationale and Therapeutic Potential of Pioglitazone for Scarring Dermatoses.

Journal: Journal of visualized experiments : JoVE

Published: June 22, 2026

Showing 1-12 of 8,846

Last Updated: 09/26/2026